Legalizing marijuana lowers demand for prescription drugs, study finds
Marijuana Industry News April 18, 2022 MJ Shareholders 0
“The reductions in drug utilization that we find could lead to significant cost savings for state Medicaid programs. The results also indicate an opportunity to reduce the harm that can come with the dangerous side effects associated with some prescription drugs,” one researcher said.
Access to marijuana via legalization lowers demand for expensive prescription medications through state Medicaid programs, according to a new study.
Cornell University researchers analyzed data from the Centers for Medicare and Medicaid Services in all 50 states from 2011 to 2019, finding a decline in the volume of prescriptions targeting pain, depression, anxiety, sleep, psychosis and seizures in states that have legalized recreational use.
“These results have important implications,” Shyam Raman, a doctoral student in the Cornell Jeb E. Brooks School of Public Policy, said in a news release.
“The reductions in drug utilization that we find could lead to significant cost savings for state Medicaid programs. The results also indicate an opportunity to reduce the harm that can come with the dangerous side effects associated with some prescription drugs,” Raman added.
Raman conducted the research, which was published April 15 in the journal Health Economics, with Indiana University doctoral student Ashley Bradford. [Read More @The Hill]
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.